Chengdu PharmaGene Technology

Chengdu PharmaGene Technology is a biotechnology company based in China that specializes in structure-based drug discovery and development. The company focuses on metabolic diseases, particularly targeting the incretin system with multi-agonist peptides and small molecules for conditions like type 2 diabetes and obesity. PharmaGene leverages its expertise in structural biology and medicinal chemistry to provide contract research services while also advancing its internal pipeline of metabolic drug candidates. Their approach integrates high-resolution structural analysis with computational modeling to optimize lead compounds for improved potency and metabolic stability.